wellrank.ai
Sign In
Estrace logo

Estrace

First cited by AI Jun 11, 2026
estrace.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Estrace, through Sep 11, 2026.

20.0%

Avg position when mentioned: 4.3 · peak 24% on Aug 12

By engine

Where Estrace is strong, and where it is invisible.

  • ChatGPT
    33.3%
  • Claude
    13.3%
  • Google AI
    13.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 152 positive mentions
  • 152 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Estrace

ChatGPTSep 11, 2026, 15:17 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” means the hormone molecule is chemically identical to the sex hormones produced by the human body (most commonly 17β‑estradiol and micronized progesterone). “Standard” HRT usually refers to FDA‑approved hormone products, which may be bioidentical (some are) or non‑bioidentical (synthetic progestins or conjugated equine estrogens). The main differences are regulation, evidence, and how they’re made — not an automatic difference in safety or effectiveness. Key points What “bioidentical” actually means Bioidentical hormones: molecules have the same chemical structure as human hormones (example: 17β‑estradiol, micronized progesterone). The term is used for both FDA‑approved products that are chemically identical (e.g., estradiol tablets/patches, micronized progesterone) and for custom‑made compounded preparations that claim to be “bioidentical.” How products are made and regulated FDA‑approved HRT: manufactured, standardized, tested for potency, purity and safety. Examples (bioidentical forms): Estrace (oral estradiol), Vivelle‑Dot or Climara (transdermal estradiol patches), EstroGel/Evamist (topical estradiol), Prometrium (micronized progesterone). These are reviewed by the FDA for manufacturing and labeled dosing. Compounded “bioidentical” hormones: made by compounding pharmacies to individualized prescriptions. They are not FDA‑approved as finished drugs, and quality, potency and consistency can vary unless the pharmacy follows high accreditation (e.g., PCAB) and performs testing. Claims vs. evidence Marketing often claims compounded bioidentical hormones are “safer” or more “natural.” There is limited high‑quality evidence that compounded products are safer or more effective than FDA‑approved bioidentical preparations. Some differences in risk relate to hormone type and route: for example, transdermal estradiol appears to carry a lower risk of venous thromboembolism than oral estrogen; micronized progesterone may have a different risk profile than synthetic progestins. But overall risks (VTE, stroke, breast cancer, cardiovascular) depend on dose, route, duration, and whether progesterone/progestin is used. Safety and testing Compounded products are less regulated; batch testing, label accuracy, and sterility can be variable. Beware of clinics that use saliva hormone testing to “customize” doses — saliva tests are not reliable for guiding HRT dosing. Blood tests and symptoms are the usual guides for management. All HRT decisions should consider medical history (personal/family breast cancer, clotting disorders, cardiovascular disease), and require follow‑up (mammography as recommended, symptom review, blood pressure, etc.). Practical approach / recommendations If you want a proven, consistent product: choose FDA‑approved options (Estrace, Vivelle‑Dot/Climara, EstroGel/Evamist for estradiol; Prometrium for micronized progesterone). These are quality‑controlled and have known dosing/safety data. If you need a very specific dose or formulation that isn’t commercially available, a reputable accredited compounding pharmacy can be considered — ask about batch testing, USP standards, and PCAB accreditation. Discuss route: transdermal (patch/gel) often lowers clot risk vs oral; vaginal estrogen is effective for local genitourinary symptoms with minimal systemic exposure. Work with a clinician experienced in menopause/HRT (e.g., a gynecologist, endocrinologist, or a clinician certified by the North American Menopause Society). Bottom line “Bioidentical” describes the chemical structure of the hormone, but it does not guarantee greater safety. For most people, using an FDA‑approved bioidentical product (when available) gives predictable dosing and quality. Compounded bioidenticals can be useful when a specific dose or formulation is needed, but they carry more uncertainty and should be used only with careful oversight by a knowledgeable clinician. If you want, tell me your symptoms, medical history, and whether you prefer pill/patch/cream so I can suggest options tailored to you.

Mentioned in position 1 of 6

Read full answer with sources →
ClaudeSep 11, 2026, 15:17 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical vs. Standard HRT Standard HRT These are conventional hormone replacement therapy products, which may include: Synthetic hormones (like medroxyprogesterone acetate) or hormones derived from animal sources (like Premarin, made from pregnant mare urine) FDA-regulated with established safety/efficacy data Standardized dosing Bioidentical Hormones These have a molecular structure identical to hormones your body naturally produces Two main categories: FDA-Approved Bioidentical Products: Estrace (estradiol) Prometrium (progesterone) Vivelle-Dot (estradiol patch) Bijuva (combined pill) These have standardized dosing and safety testing Compounded Bioidentical Hormones: Custom-made by compounding pharmacies Often marketed as more "personalized" NOT FDA-approved individually Less quality control oversight Key Takeaway The term "bioidentical" is largely a marketing distinction - some FDA-approved standard HRT products are already bioidentical. The FDA-approved versions are generally considered safer due to rigorous testing. Always consult your doctor or an endocrinologist before choosing, as individual needs vary significantly.

Mentioned in position 2 of 5

Read full answer with sources →
ChatGPTSep 10, 2026, 15:15 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Bioidentical hormone replacement therapy (BHRT) can be effective for menopausal symptoms, but safety depends on what exactly is being used and who is giving it. Most major medical organizations recommend using FDA‑approved hormone products under physician supervision and advise caution about compounded (“custom”) BHRT because of quality, dosing, and safety uncertainties. What “bioidentical” means “Bioidentical” usually means the hormones have the same chemical structure as the hormones made by your body (for example, estradiol and micronized progesterone). Some FDA‑approved products are bioidentical; others marketed as “natural” or “custom” are compounded in pharmacies and may not be FDA‑tested. What doctors and major organizations say North American Menopause Society (NAMS), American College of Obstetricians & Gynecologists (ACOG), and The Endocrine Society: recommend evidence‑based use of hormone therapy for appropriate patients and generally prefer FDA‑approved products. They warn that compounded BHRT is not supported by evidence of superior safety or effectiveness. U.S. Food and Drug Administration (FDA): warns that compounded hormones are not reviewed for safety, potency, purity, or efficacy and objects to marketing implying they’re safer than FDA‑approved drugs. Many clinicians: say hormone therapy can be appropriate for moderate–severe menopausal symptoms (hot flashes, vaginal atrophy), sexual dysfunction in some cases, and that risks vary by age, health status, dose, and duration. Key safety points Benefits: very effective for hot flashes, night sweats, vaginal dryness, and can improve quality of life. Risks: include increased risk of blood clots and stroke (higher with oral estrogens), possible increased breast cancer risk with combined estrogen‑progestin depending on duration, and other side effects. Risks are lower for younger women (<60) and for shorter treatment durations; personalized risk assessment is essential. Compounded BHRT: major concerns are inconsistent dosing, contamination, lack of labeling or clinical trial evidence, and unreliable hormone level testing used to “customize” doses (salivary hormone testing is not recommended for guiding therapy). Testosterone for women: some off‑label use may help low libido, but there is limited long‑term safety data and no widely accepted FDA‑approved female testosterone product in the U.S. FDA‑approved products doctors commonly prescribe (examples) Estradiol patches/gels/pills (examples: Climara, Vivelle‑Dot, Alora, Estrace) — estradiol is bioidentical to human estrogen. Micronized progesterone (Prometrium) — a bioidentical oral progesterone product. Conjugated equine estrogens (Premarin) and medroxyprogesterone acetate (Provera) are older, FDA‑approved HRT options (not “bioidentical” in the strict sense for all components). What to do if you’re considering BHRT Talk with a clinician experienced in menopause (gynecologist, reproductive endocrinologist, or menopause specialist). Discuss your symptoms, medical history (breast cancer, blood clots, liver disease, stroke, cardiovascular disease), and family history. Prefer FDA‑approved products when possible; avoid relying on salivary hormone tests to set doses. If considering a compounded product, ask about the pharmacy’s testing standards, sterility, and why an FDA‑approved product won’t work for you. Use the lowest effective dose for the shortest time needed; plan regular follow‑up and reassess risks/benefits periodically. Bottom line BHRT using FDA‑approved, bioidentical hormones (like estradiol and micronized progesterone) is a reasonable, evidence‑based option for many menopausal women when prescribed and monitored by a physician. Compounded, “custom” BHRT carries additional uncertainty and is not generally recommended by major medical societies. If you want, tell me your age, symptoms, and medical history (or the issues you’re concerned about) and I can give more tailored information or questions to bring to your doctor.

Mentioned in position 4 of 7

Read full answer with sources →
Google AISep 10, 2026, 15:15 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

The question of BHRT safety and what doctors say is complex, largely because the term "bioidentical hormones" can refer to two very different categories of products. Let's break it down: What Are Bioidentical Hormones? Bioidentical hormones are hormones that are chemically identical to those your body produces naturally. Examples include estradiol, progesterone, and testosterone. The appeal is often that they are "natural" or "customized." However, there's a crucial distinction: FDA-Approved Bioidentical Hormones: These are pharmaceutical products that contain bioidentical hormones, have undergone rigorous testing for safety and efficacy, are manufactured to strict standards, and are approved by the U.S. Food and Drug Administration (FDA). Compounded Bioidentical Hormones (cBHRT): These are custom-made by compounding pharmacies based on a doctor's prescription, often using a "cocktail" of hormones and sometimes based on saliva tests. These products are NOT FDA-approved for safety or efficacy as a unique formulation. Is BHRT Safe? What Do Doctors Say? The answer largely depends on which type of bioidentical hormones you're referring to: FDA-Approved Bioidentical Hormones Safety: Yes, when prescribed and monitored by a qualified physician, these are generally considered safe and effective for treating menopausal symptoms, hormone deficiencies, and other conditions. Their safety and efficacy have been proven through extensive clinical trials. What Doctors Say: Mainstream medical organizations (such as The North American Menopause Society - NAMS, The American College of Obstetricians and Gynecologists - ACOG, and The Endocrine Society) fully endorse and recommend FDA-approved bioidentical hormones as part of conventional hormone replacement therapy (HRT) for appropriate candidates. They are a cornerstone of evidence-based medical practice. Why they are accepted: They are rigorously tested, have standardized dosages, clear package inserts detailing risks and benefits, and strict quality control. Compounded Bioidentical Hormones (cBHRT) Safety: This is where the major controversy and safety concerns lie. Mainstream medical organizations generally advise against the use of compounded bioidentical hormones due to a lack of evidence for their safety and effectiveness, and potential risks. What Doctors Say (Mainstream): The vast majority of medical professionals and major professional societies do NOT recommend or endorse compounded BHRT. Why the concern? Lack of FDA Oversight: Compounded products do not undergo the rigorous testing for safety, purity, potency, and efficacy that FDA-approved drugs do. This means there's no guarantee you're getting the dose specified, or that the product is free from contaminants. Unproven Claims: There's no scientific evidence to support claims that compounded BHRT is safer or more effective than FDA-approved hormone therapy. Inconsistent Dosing: Compounded products can have significant variability in hormone content, leading to underdosing (meaning no benefit) or overdosing (meaning increased risks). Unreliable Testing: Many cBHRT prescribers rely on saliva testing to "customize" hormone dosages, but these tests are not considered reliable by mainstream medicine for guiding hormone therapy. Blood tests are the standard. Misleading Marketing: The term "bioidentical" can be misused to imply superior safety or efficacy, which is not supported by evidence for compounded products. Lack of Package Inserts: Unlike FDA-approved drugs, compounded preparations do not come with detailed patient information on risks, benefits, and side effects. Why Some Doctors Prescribe Them: A smaller segment of practitioners, often those in "integrative" or "functional" medicine, do prescribe compounded BHRT. Their rationale often revolves around the idea of "individualized" treatment, patient preference for "natural" options, or addressing specific patient intolerances to inactive ingredients in approved formulations (though this is rare). However, even among these practitioners, the scientific evidence base remains weak. Specific Brands & Services To ensure safety and efficacy when considering hormone therapy, always prioritize FDA-approved options. Recommended FDA-Approved Bioidentical Hormone Brands: These are widely available prescription medications that doctors routinely prescribe: Estradiol (Estrogen): Oral: Estrace (oral tablet) Transdermal Patch: Vivelle-Dot, Climara, Minivelle, Dotti Gel/Spray: Estrogel, Divigel, Elestrin (gels), Evamist (spray) Vaginal (for localized symptoms): Estrace Vaginal Cream, Vagifem, Estring Progesterone: Oral: Prometrium (micronized progesterone capsules) Testosterone (for women, often off-label; for men): Gel/Solution: AndroGel, Testim, Fortesta, Axiron (for men) (Specific FDA-approved testosterone products for women's low libido are very limited, often doctors will prescribe off-label or specialized formulations, but these are still regulated.) How to Find a Reputable Doctor: For Hormone Therapy (including FDA-approved bioidentical hormones): Obstetrician-Gynecologist (OB/GYN): Many OB/GYNs are highly knowledgeable about menopause and hormone therapy. Endocrinologist: These specialists focus on hormones and can manage complex cases. NAMS Certified Menopause Practitioners (NCMP): NAMS offers certification for healthcare providers who have demonstrated expertise in menopause care. You can find a practitioner near you on the NAMS website (menopause.org). This is an excellent service for finding evidence-based care. If you are considering any type of hormone therapy: Consult with a Board-Certified Physician: Start with your primary care doctor, OB/GYN, or an endocrinologist. Discuss Your Symptoms and Medical History: A thorough evaluation is crucial. Understand the Risks and Benefits: Discuss all options, including lifestyle changes, non-hormonal treatments, and FDA-approved hormone therapies. Ask for Evidence: If a doctor suggests compounded hormones, ask for the scientific evidence (peer-reviewed studies, not just anecdotal claims) to support their safety and efficacy for your specific condition. If they can't provide it, or if it contradicts major medical guidelines, be very cautious. In summary, while FDA-approved bioidentical hormones are considered safe and effective for appropriate candidates by the medical establishment, compounded bioidentical hormones (cBHRT) are widely viewed with skepticism and concern by mainstream doctors due to a lack of evidence and potential safety issues. Always prioritize evidence-based medicine and FDA-approved products.

Mentioned in position 1 of 16

Read full answer with sources →
ClaudeSep 10, 2026, 15:15 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT): What You Should Know What Doctors Generally Say Medical opinion is mixed but evolving: Mainstream medical organizations (like the FDA and ACOG) note that: "Bioidentical" is largely a marketing term, not a strict medical classification FDA-approved bioidentical options exist and have been tested for safety Custom-compounded BHRT from compounding pharmacies has less quality control FDA-Approved Bioidentical Options (Considered Safer) These have undergone clinical testing: Estrace (estradiol pills) Vivelle-Dot or Climara (estradiol patches) Prometrium (bioidentical progesterone capsule) Bijuva (combined estradiol/progesterone) What to Be Cautious About Compounded BHRT from specialty pharmacies lacks FDA oversight Claims that it's automatically "safer than synthetic" hormones are not fully proven Saliva testing used by some BHRT providers is considered unreliable by most endocrinologists Bottom Line Talk to a board-certified endocrinologist or OB-GYN rather than a general wellness clinic. Organizations like The Menopause Society (NAMS) provide evidence-based guidelines your doctor can reference. Individual risk factors matter enormously for safety.

Mentioned in position 1 of 5

Read full answer with sources →
ChatGPTSep 9, 2026, 15:24 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

At 47 with hot flashes and poor sleep you’re most likely in perimenopause/menopause. There are several effective options — lifestyle/behavioral changes, medications (hormonal and non‑hormonal), and sleep‑focused therapies. The right choice depends on your symptoms, medical history, and personal risks (especially any history of breast cancer, blood clots, stroke, liver disease, or uncontrolled heart disease). Talk with your primary care doctor, gynecologist, or a menopause specialist to choose and monitor therapy. Below is a practical overview with specific brands/services you can discuss. 1) Hormone therapy (most effective for hot flashes and often improves sleep) What it is: Systemic estrogen (with a progestin if you still have a uterus) reduces hot flashes and often restores sleep. Routes & example brands: Transdermal patch: Vivelle‑Dot, Climara — steady hormone levels, lower clot vs some oral forms, good if you have nausea or GI issues. Topical gel: Estrogel (estradiol) — flexible dosing. Oral estrogen: Estrace (estradiol), Premarin (conjugated estrogens) — effective but oral estrogen has higher effect on clotting markers. Combined (for women with a uterus): Activella (estradiol + norethindrone), Prempro. Benefits vs risks: Most effective for hot flashes and night sweats, improves sleep. Risks include higher risk of blood clots, stroke (especially starting late), and a small increase in breast cancer risk with long‑term combined therapy. Generally recommended to use the lowest effective dose for the shortest needed time; individualized decision with your clinician. 2) Non‑hormonal medicines (if hormones are not appropriate or preferred) Antidepressants/SNRIs: Low‑dose paroxetine (Brisdelle 7.5 mg) — FDA approved for hot flashes. Important: paroxetine interferes with tamoxifen (if you are taking tamoxifen for breast cancer prevention/treatment, avoid). Venlafaxine (Effexor) and desvenlafaxine — often reduce hot flashes fairly quickly. Gabapentin (Neurontin) — useful for night sweats, taken at night in divided doses. Clonidine (Catapres) — modest benefit for hot flashes, may cause dry mouth, dizziness. For sleep specifically: low‑dose doxepin (Silenor) for sleep maintenance, trazodone commonly used off‑label, or short courses of zolpidem (Ambien) or eszopiclone (Lunesta) for insomnia — discuss dependency and side effects with your clinician. Notes: These meds help hot flashes or sleep but have side effects; choose based on other conditions and interactions. 3) Behavioral and sleep‑focused treatments (first‑line for insomnia) Cognitive Behavioral Therapy for Insomnia (CBT‑I) is a strongly evidence‑based treatment and often more durable than sleeping pills. Online CBT‑I programs: Sleepio and SHUTi have good evidence and are easy options. Ask for a referral to a CBT‑I trained clinician (many psychologists and sleep clinics offer this). Sleep hygiene and habits: cool, dark, consistent sleep schedule; avoid caffeine and alcohol near bedtime; limit evening screen time; keep bedroom cool and layered bedding. Bed/cooling products: consider a bedside fan and cooling mattress/pad such as ChiliSleep (formerly ChiliPad) or Eight Sleep if night sweats make falling/staying asleep hard. 4) Lifestyle & self‑care to reduce hot flashes and improve sleep Avoid triggers (hot drinks, spicy foods, alcohol, caffeine, hot rooms). Dress in layers, moisture‑wicking sleepwear, use a fan. Regular aerobic exercise and weight management can help overall well‑being (effects on hot flashes are variable). Mind‑body practices: mindfulness, paced respiration, and yoga may reduce symptom bother. 5) Complementary therapies (mixed evidence) Soy/isoflavone supplements — small benefit for some women. Black cohosh — mixed evidence and quality control concerns; discuss with clinician. Acupuncture — some women report improvement, evidence is limited. 6) When to see a specialist or pursue testing If hot flashes or insomnia severely impair daily life, or if you have risk factors (breast cancer, history of blood clots, stroke, heart disease), see your clinician for individualized care. If sleepiness, loud snoring, or witnessed apneas occur, consider a sleep clinic evaluation for sleep apnea (which can be worsened in menopause). Your doctor may want baseline screening (mammogram per guidelines) and to discuss cardiovascular and clotting risk before starting hormone therapy. Next steps I recommend Make an appointment with your primary care clinician or gynecologist and discuss: severity of hot flashes and sleep problems, past medical history (breast cancer, clotting disorders, migraines), and current medications (e.g., tamoxifen). If you want a low‑burden start, ask about transdermal estradiol (patch) versus a nonhormonal option like venlafaxine or gabapentin — pros/cons will depend on your medical history. If insomnia is your main issue, ask for CBT‑I referral or try a reputable online CBT‑I program (Sleepio or SHUTi). If helpful, I can draft questions to bring to your clinician or help you compare two specific treatments. If you want, tell me: do you have a history of breast cancer, clotting problems, heart disease, migraines, or are you on tamoxifen or other medications? I can give more specific guidance based on that.

Mentioned in position 4 of 18

Read full answer with sources →

TL;DR

Estrace is a brand of estradiol, a bioidentical estrogen produced by pharmaceutical manufacturer Allergan (now part of AbbVie), used primarily to treat symptoms of menopause and other estrogen-deficiency conditions. The brand is available as an oral tablet and as a vaginal cream. According to WellRank's latest index, Estrace ranks fifth in the Menopause and women's health category with 20% AI visibility and sixteenth in BHRT with 13% visibility, placing it among the most consistently cited hormone therapy brands in AI-generated answers.

Company Overview

Estrace is a branded pharmaceutical product rather than an independent company; its formulations have been owned by several pharmaceutical entities over the years, most recently falling under AbbVie following its acquisition of Allergan. The product is sold through licensed pharmacies and healthcare providers under a traditional prescription drug model. Allergan developed and marketed a broad portfolio of women's health products, and Estrace has been a long-standing entry in that portfolio.

Product Features

  • Estrace oral tablets (estradiol 0.5 mg, 1 mg, and 2 mg) for systemic menopause symptom relief
  • Estrace vaginal cream for treating vaginal atrophy and urogenital symptoms of menopause
  • Bioidentical estradiol formulation chemically identical to endogenous human estrogen
  • Available by prescription through retail and specialty pharmacies
  • FDA-approved hormone therapy with an established clinical track record

Target Market

Estrace primarily serves perimenopausal and postmenopausal women in the United States who require estrogen replacement therapy to manage hot flashes, vaginal atrophy, and other estrogen-deficiency symptoms. It is also indicated for certain cases of female hypogonadism and prevention of postmenopausal osteoporosis. The brand is distributed throughout the US market via the traditional prescription pharmacy channel.

Buyer Personas

  • A perimenopausal woman in her late 40s working with a gynecologist to manage worsening hot flashes and sleep disruption.
  • A postmenopausal woman in her 50s or 60s seeking localized vaginal estrogen therapy for dryness and discomfort.
  • A younger woman with surgically induced menopause who requires systemic estrogen replacement at a relatively early age.
  • A patient transitioning from a compounded bioidentical product to an FDA-approved branded estradiol option at her provider's recommendation.

Funding & Performance

Estrace is a prescription pharmaceutical product sold by AbbVie, a publicly traded company (NYSE: ABBV). Revenue attributable specifically to the Estrace brand is not broken out in AbbVie's public financial disclosures.

Recent Developments

The broader hormone replacement therapy landscape has shifted meaningfully following updated guidance from regulatory and health bodies that have revisited earlier, more restrictive positions on HRT use, a development covered in an FDA press announcement on revised HRT warnings. This regulatory context has renewed clinician and patient interest in established estradiol brands like Estrace. Academic literature, such as a BCMJ review of HRT in older women, has also contributed to broadening the perceived eligible population for estrogen therapy.

Competitive Landscape

Estrace competes directly with other estradiol delivery formats and branded hormone therapies that AI engines frequently mention alongside it, including the transdermal patches Vivelle-Dot and Climara, the vaginal ring Estring, and the localized vaginal tablet Vagifem. It also appears in AI answers alongside progestogen products such as Prometrium and Provera, reflecting how clinicians often discuss combination regimens. Premarin, a conjugated equine estrogen product, represents the main non-bioidentical competitor in AI co-mention patterns. Resources like GoodRx's overview of bioidentical hormone therapy frequently group Estrace with these alternatives when comparing options for menopausal women.

Estrace vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Estrace logo
EstraceThis brand
#5
20.0%
Vivelle-Dot logo
Vivelle-Dot

285 shared answers

#4
22.2%
Prometrium logo
Prometrium

237 shared answers

#9
15.6%
Climara logo
Climara

236 shared answers

#7
17.8%
Premarin logo
Premarin

159 shared answers

#18
11.1%

Email me when overtakes Estrace

One email the day the ranks flip. Nothing else.

User Sentiment

Of the 210 AI mentions tracked by WellRank, 105 are positive and 105 are neutral, with zero mixed or cautious mentions, indicating that AI engines present Estrace in a consistently favorable or matter-of-fact clinical light without notable reservations. This split likely reflects the brand's FDA-approved status and its long-standing use in evidence-based prescribing guidelines. Sources such as the Menopause Clinic's treatment cost schedule and Medivera Rx's BHRT cost guide cite the brand in informational contexts that reinforce its credibility.

Pricing

Estrace is a prescription product; retail pricing varies by pharmacy, dosage form, and whether a patient uses insurance or a discount program. Generic estradiol tablets are widely available and are typically less expensive than the branded Estrace product. Exact out-of-pocket costs are not published by the manufacturer and depend heavily on insurance coverage, though cost-comparison resources such as Asheville Rx's BHRT cost breakdown and Live Revital's BHRT pricing guide provide general context for where branded estradiol products sit in the broader HRT cost landscape.

Sources cited around Estrace

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Estrace weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Estrace? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.